Immunic
IMUX
IMUX
50 hedge funds and large institutions have $22.7M invested in Immunic in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less capital invested
Capital invested by funds: $27M → $22.7M (-$4.27M)
30% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
50
Holding in Top 10
–
Calls
$874K
Puts
$392K
Top Buyers
| 1 | +$493K | |
| 2 | +$382K | |
| 3 | +$154K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$81.3K |
| 5 |
SFP
Sweet Financial Partners
Fairmont,
Minnesota
|
+$44.7K |
Top Sellers
| 1 | -$1.69M | |
| 2 | -$752K | |
| 3 | -$690K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$662K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$361K |